Shijian Quan

571 citations
21 papers · 446 indexed · h-index 12
Topics
Chronic Kidney Disease and Diabetes (4 papers)Traditional Chinese Medicine Analysis (3 papers)Pharmacological Effects of Natural Compounds (3 papers)

In The Last Decade

Shijian Quan

21 papers receiving 444 citations

Peers

Shijian Quan
Comparison fields: 5 of 81
  • Molecular Biology 189
  • Physiology 74
  • Plant Science 65
  • Pharmacology 62
  • Complementary and alternative medicine 62
Replace Diana Barrera‐Oviedo with:
Diana Barrera‐Oviedo Mexico
Yaqin Wei China
Maha A. Alamin Saudi Arabia
Guozhu Han China
Lingpeng Xie China
Zhirui Fang China
Maha M. El‐Sawalhi Egypt
Pierre Watcho United States
Minghao Yuan China
Shijian Quan relative to Diana Barrera‐Oviedo Mexico Diana Barrera‐Oviedo's profile →
Citations per field
00.5×2.6×
Diana Barrera‐Oviedo · 1×
Citations per year

Countries citing papers authored by Shijian Quan

Since Specialization
Citations

This map shows the geographic impact of Shijian Quan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shijian Quan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shijian Quan more than expected).

Fields of papers citing papers by Shijian Quan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shijian Quan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shijian Quan. The network helps show where Shijian Quan may publish in the future.

Co-authorship network of co-authors of Shijian Quan

This figure shows the co-authorship network connecting the top 25 collaborators of Shijian Quan. A scholar is included among the top collaborators of Shijian Quan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shijian Quan. Shijian Quan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 10
3 17
4 9
5 5
6 40
7 2
8 8
9 50
10 17
11 37
12 85
13 18
14 13
15 32
16 18
17 3
18 11
19 46
20 20

About Shijian Quan

Shijian Quan is a scholar working on Complementary and alternative medicine, Pharmacology and Nephrology, having authored 21 papers that have together received 446 indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (4 papers), Traditional Chinese Medicine Analysis (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). The work is most often cited by research in Biological Psychiatry (25 citations), Complementary and alternative medicine (62 citations) and Pharmacology (59 citations). Shijian Quan has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Heqing Huang, Yan Yang, Renbin Liu, Kai Zhuang, Zeyuan Lin, Haiming Xiao, Heqing Huang, Meng Zhang, Zhiquan Chen and Xiaohong Sun. Their work appears in journals such as Molecules, Journal of Ethnopharmacology and Experimental Cell Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026